Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era
- 1 June 2012
- journal article
- Published by Elsevier BV in Lung Cancer
- Vol. 76 (3), 387-392
- https://doi.org/10.1016/j.lungcan.2011.11.022
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Leptomeningeal MetastasisSeminars in Neurology, 2010
- New Strategies in the Management of Leptomeningeal MetastasesArchives of Neurology, 2010
- Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKILung Cancer, 2008
- Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumorsJournal of Neuro-Oncology, 2008
- Leptomeningeal metastasis: survival and prognostic factors in 155 patientsJournal of the Neurological Sciences, 2004
- Pronostic factors of synchronous brain metastases from lung cancerLung Cancer, 2001
- Leptomeningeal carcinomatosisCancer Treatment Reviews, 1999
- Carcinoma Meningitis Secondary to Non–Small Cell Lung CancerArchives of Neurology, 1998
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patientsCancer, 1982